ID   SACC-83
AC   CVCL_H589
SY   SACC83
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00034
DR   GEO; GSM1670400
DR   PharmacoDB; SACC83_1341_2019
DR   Wikidata; Q54952051
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=2163817;
RX   PubMed=18620900;
RX   PubMed=23673996;
RX   PubMed=27397505;
CC   Omics: Transcriptome analysis.
ST   Source(s): PubMed=23673996
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,16,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,16,17
ST   FGA: 18,21
ST   Penta D: 9,12
ST   vWA: 14,16
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 06-09-19; Version: 11
//
RX   DOI=10.4103/2468-5585.200513;
RA   Liu N.-N., Zhang S.-L., Chen W.;
RT   "The cross-contaminated cell lines of adenoid cystic carcinoma:
RT   a crucial concern.";
RL   Transl. Surg. 2:10-13(2017).
//
RX   PubMed=2163817;
RA   Li S.-L., Li X.-P., Zhang K.-H.;
RT   "Establishment of human salivary adenoid cystic carcinoma cell line
RT   SACC-83 and its biological characteristics.";
RL   Zhonghua Kou Qiang Yi Xue Za Zhi 25:29-31(1990).
//
RX   PubMed=18620900; DOI=10.1016/j.oraloncology.2008.04.009;
RA   Hu K., Li S.-L., Gan Y.-H., Wang C.-Y., Yu G.-Y.;
RT   "Epiregulin promotes migration and invasion of salivary adenoid cystic
RT   carcinoma cell line SACC-83 through activation of ERK and Akt.";
RL   Oral Oncol. 45:156-163(2009).
//
RX   PubMed=23673996; DOI=10.3892/or.2013.2460;
RA   Wang L., Wang Y.-X., Bian H., Pu Y.-F., Guo C.-B.;
RT   "Molecular characteristics of homologous salivary adenoid cystic
RT   carcinoma cell lines with different lung metastasis ability.";
RL   Oncol. Rep. 30:207-212(2013).
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M.,
RA   Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M.,
RA   Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A.,
RA   Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//